Champions Oncology, Inc.
CSBR
$7.49
-$0.68-8.32%
| 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 517.45% | -44.55% | 1,304.59% | 95.69% | -22.16% |
| Total Depreciation and Amortization | -0.25% | -11.14% | -1.75% | -4.99% | -0.62% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 446.81% | -80.25% | -55.22% | 40.79% | 78.91% |
| Change in Net Operating Assets | -226.93% | 21.95% | 40.29% | -960.53% | -78.62% |
| Cash from Operations | 273.14% | -191.00% | 117.13% | -97.61% | -256.03% |
| Capital Expenditure | 55.32% | -- | -- | 220.65% | -16.46% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 55.32% | -- | -- | 220.65% | -16.46% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -2.70% | 0.00% | 74.66% | -329.41% | 54.05% |
| Issuance of Common Stock | -86.23% | -- | -- | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | 100.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -100.00% | 745.95% | 74.48% | -326.47% | -125.37% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 424.64% | -150.36% | 114.81% | -77.03% | -262.27% |
